Rejected at 5:57 p.m. Mar, 25, 2025 ] by mitchelnelson
Author: madelsmur
Related Note: 1503254970224
Rationale for change

On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis.
The new regimen is 4 months w/ moxifloxacin in place of ethambutol.
Source: Society Guidelines - https://www.atsjournals.org/doi/full/10.1164/rccm.202410-2096ST

Rejection reason

Please resubmit with an acceptable source. Please review suggestion guidelines, specifically rule #1: 📚 AnKing Step Deck Submission Guidelines

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
#AK_Step1_v12::#Bootcamp::Microbiology::08_Mycobacteria::04_Pulmonary_Tuberculosis_Diagnostics_And_Management #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::41_Mycobacterium_Tuberculosis #PANCE::EOR::Family_med #AK_Step1_v12::#OME_banner::Basic_Science::12_Renal #AK_Step2_v12::#Resources_by_rotation::IM::uw::renal::renal_dorian #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::24_Ethambutol_&_Pyrazinamide #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::19_Mycobacteria::*Mycobacterium_Tuberculosis #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::01_Antimycobacterials #AK_Step1_v12::#Bootcamp::Microbiology::34_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::22_Isoniazid #AK_Step1_v12::#Bootcamp::Microbiology::33_Infectious_Neuropathology::04_Atypical_Meningoencephalitis #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::20_Tuberculosis #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Renal #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Ethambutol #AK_Step1_v12::#Pixorize::04_Microbiology::06_Bacteria-Gram_Indeterminate::02_Mycobacterium_tuberculosis:_Disease_(TB) #AK_Other::Card_Features::^One_By_One #AK_Step2_v12::#Bootcamp::Pediatrics::03_Infectious_Disease::02_Airway_and_Respiratory_Infections::06_Tuberculosis #AK_Step1_v12::#AMBOSS::pNaLXO #AK_Step1_v12::#B&B::20_Pulm::03_Other_Pulmonary_Topics::08_Tuberculosis_Diagnosis_&_Treatment #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Isoniazid #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::01_Tuberculosis_Drugs #AK_Step2_v12::#B&B::08_Infectious_Disease::04_Other::04_Tuberculosis #AK_Step2_v12::Original_decks::Dorian::im::uw::renal #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#Bootcamp::Microbiology::34_Antibiotics::23_Rifamycins #AK_Step1_v12::#OME_banner #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::01_Mycobacterium_Tuberculosis #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::23_Isoniazid_(RIPE) #AK_Step2_v12::#Resources_by_rotation::IM::uw::renal::renal_zanki #AK_Step2_v12::#UWorld::COMLEX::104297 #AK_Step2_v12::#UWorld::Step::19425 #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Pyrazinamide #PANCE::PULM::infectious_disorders